You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES
NEWS / CORPORATE / .........

CORPORATE - 30-04-2015

Kedrion SpA’s Shareholders approve 2014 financial statement

On 27th April 2015, Kedrion SpA’s Shareholders’ Meeting approved the 2014 financial statement. A 466 million euros’ turnover with a 9,8% rise on 2013, international sales accounting for 67,9% of the overall turnover, a 23,8% adjusted EBITDA, a net profit of 42 million euros: here are the key figures of 2014’s statement of accounts for Kedrion SpA.

The company showed its usual bent for expansion on the global markets in 2014 as well, above all in the United States where it exceeded 159 million euros this year.

For more information please contact: pressoffice@kedrion.com